Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zee, A H Maitland-van der
639  Ergebnisse:
Personensuche X
?
1

Patients Benefit From Genetics-Guided Coumarin Anticoagulan..:

Zee, A H Maitland-van der ; Daly, A K ; Kamali, F...
Clinical Pharmacology & Therapeutics.  96 (2014)  1 - p. 15-17 , 2014
Link: https://doi.org/10.1038/..
 
?
2

Determinants of DNA Yield and Purity Collected with Buccal ..:

van Wieren-de Wijer, D. B. M. A. ; Zee, A. H. Maitland-van der ; de Boer, A....
European Journal of Epidemiology.  24 (2009)  11 - p. 677-682 , 2009
Link: https://www.jstor.org/st..
 
?
3

Epigenome-Wide Association Studies of the Fractional Exhale..:

Martin-Almeida, Mario ; Perez-Garcia, Javier ; Herrera-Luis, Esther...
Biomedicines.  11 (2023)  3 - p. 676 , 2023
Link: https://doi.org/10.3390/..
 
?
4

ePS6.01 Targeted analysis of volatile organic compounds for..:

Kos, R. ; Brinkman, P. ; Neerincx, A.H....
Journal of Cystic Fibrosis.  19 (2020)  - p. S52 , 2020
Link: https://doi.org/10.1016/..
 
?
5

P207 Start of lumacaftor/ivacaftor in adult cystic fibrosis..:

Neerincx, A.H. ; Whiteson, K. ; Phan, J.L....
Journal of Cystic Fibrosis.  19 (2020)  - p. S115 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Prediction of response to anti-PD-1 therapy in patients wit..:

de Vries, R. ; Muller, M. ; van der Noort, V....
Annals of Oncology.  30 (2019)  10 - p. 1660-1666 , 2019
Link: https://doi.org/10.1093/..
 
?
7

Markers of Pulmonary Oxygen Toxicity in Hyperbaric Oxygen T..:

Wingelaar, T. T. ; Brinkman, P. ; van Ooij, P. J. A. M....
Frontiers in Physiology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
8

NOACs replace VKA as preferred oral anticoagulant among new..:

van den Heuvel, J. M. ; Hövels, A. M. ; Büller, H. R....
Thrombosis Journal.  16 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
9

P047 Detection of Pseudomonas aeruginosa in exhaled breath ..:

Neerincx, A.H. ; Brinkman, P. ; van der Gouwe, P....
Journal of Cystic Fibrosis.  17 (2018)  - p. S72 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Atopic dermatitis characteristics and medication-use patter..:

van der Lee, M. ; Arabkhazaeli, A. ; van Erp, F. C....
Clinical and Experimental Dermatology.  42 (2017)  5 - p. 503-508 , 2017
Link: https://doi.org/10.1111/..
 
?
11

Risk of acute myocardial infarction after discontinuation o..:

Alharbi, F F ; Souverein, P C ; de Groot, M C...
Journal of Human Hypertension.  31 (2017)  8 - p. 537-544 , 2017
Link: https://doi.org/10.1038/..
 
?
12

Age-stratified outcome of a genotype-guided dosing algorith..:

Zhang, Y. ; de Boer, A. ; Verhoef, T. I....
Journal of Thrombosis and Haemostasis.  15 (2017)  3 - p. 454-464 , 2017
Link: https://doi.org/10.1111/..
 
?
13

Dosing algorithms for vitamin K antagonists acrossVKORC1and..:

Baranova, E. V. ; Verhoef, T. I. ; Ragia, G....
Journal of Thrombosis and Haemostasis.  15 (2017)  3 - p. 465-472 , 2017
Link: https://doi.org/10.1111/..
 
?
14

ST13polymorphisms and their effect on exacerbations in ster..:

Vijverberg, S. J. H. ; Koster, E. S. ; Tavendale, R....
Clinical & Experimental Allergy.  45 (2015)  6 - p. 1051-1059 , 2015
Link: https://doi.org/10.1111/..
 
?
15

HMG-coenzyme A reductase inhibition, type 2 diabetes, and b..:

Swerdlow, Daniel I ; Preiss, David ; Kuchenbaecker, Karoline B...
https://acuresearchbank.acu.edu.au/item/85qq2/hmg-coenzyme-a-reductase-inhibition-type-2-diabetes-and-bodyweight-evidence-from-genetic-analysis-and-randomised-trials.  , 2015
Link: https://acuresearchbank...
 
1-15